Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment.
2025 · 4th Quarter (Oct 1 - Dec 31)
NATIONAL ASSOCIATION OF PROTON THERAPY
Filed by FORBES-TATE.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 18, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- FORBES-TATE
- Filing UUID
- a427d1ab-6601-458d-9862-5166b3cb6125
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2026 Labor-HHS appropriations process.
Issues pertaining to veterans' access to proton therapy.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.